Multiple Myeloma and Infections: Characterizing the Risks
Despite newer agents being available to patients with multiple myeloma, the rate of infections in this patient population has remained relatively unchanged.
Multiple Myeloma
MULTIPLE MYELOMA ADVISOR
FEATURED CONTENT
-
-
Predicting PD-1/PD-L1 Immunotherapy Responses
Finding biomarkers that can broadly and reliably predict immunotherapy outcomes for patients with cancer remains an elusive “holy grail,” said Dr Ott. -
Myeloma Trial Aims to Use Genetic Profile for Treatment Optimization
To improve options for patients with refractory disease, researchers seek to bolster data behind genetic profiling as a way to guide the selection of treatment. -
clonoSEQ and MRD Testing in Multiple Myeloma and ALL
Medicare coverage has been announced for Adaptive Biotechnologies’ clonoSEQ® next-generation sequencing assay for the detection of minimal residual disease (MRD) after treatment for multiple myeloma or B-cell acute lymphoblastic leukemia (ALL) — a key step toward its use for patient care in cancer clinics in the United States.1,2The FDA announced regulatory approval for the assay… -
Thawing Frozen Cancer Drug Labels
As medical care rapidly evolves, there’s really no debate over the potential for drug labels to become outdated, particularly in the high stakes world of cancer treatment. The question is how best to ameliorate the problem, while still protecting the process from financial and other conflicts. Off-label prescribing of cancer drugs is common, occurring 30%…
VIDEO SERIES
MULTIPLE MYELOMA NEWS
Carfilzomib Dosing and Scheduling in Newly Diagnosed Multiple Myeloma
Comparing Efficacy and Safety of Auto-HCT in Older and Younger Patients With Multiple Myeloma
The Incidence of Some Obesity-Related Cancers Is Increasing Among Young Adults
Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
Depth of Response Translates Into Real-World Benefit in Multiple Myeloma
Want to read more?
Please login or register first to view this content.
Next post in Multiple Myeloma
